Ligand Reports First Quarter 2026 Financial Results
Go back to Ligand Reports First Quarter 2026 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 291.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $291.77 | 52 Week High | $139.79 | |||
| Open | $291.77 | 52 Week Low | $82.07 | |||
| Day High | $291.77 | P/E | 678.53 | |||
| Day Low | $291.77 | EPS | $0.43 | |||
| Volume | 811 | |||||

